Barry Callebaut AG
SIX:BARN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 230
1 633
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Barry Callebaut AG
Intrinsic Value
Barry Callebaut AG engages in the manufacture and trade of cocoa, chocolate, and confectionery products. [ Read More ]
The intrinsic value of one
BARN
stock under the Base Case scenario is
1 940.98
CHF.
Compared to the current market price of 1 408 CHF,
Barry Callebaut AG
is
Undervalued by 27%.
Barry Callebaut AG's market capitalization is 7.7B CHF.
BARN stock price is 1 408 CHF.
BARN stock price (1408 CHF) is 27% less than its Intrinsic Value (1 940.98 CHF).
BARN stock price (1408 CHF) is 43% less than its Relative Value (2 467.09 CHF). Open Relative Valuation
BARN has upside potential of 24% compared to the average analyst price target.
Open Wall St Estimates
BARN's ROE (Return on Equity) for the past 12 months is positive and is equal to 10%.
BARN's ROIC (Return on Invested Capital) has decreased in the last 3 years from 7% to 5%.
BARN has positive three-year average ROIC (Return on Invested Capital): 9%. The company is efficient at using invested capital to generate operating income.
BARN's Revenue has grown by 8% over the past 12 months.
BARN's ROE (Return on Equity) has decreased in the last 3 years from 13% to 10%.
BARN has negative Free Cash Flow for the last twelve months.
BARN has positive Gross Profit for the last twelve months.
BARN has positive Operating Income for the last twelve months.
BARN's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 5%.
BARN's short-term assets (10B CHF) exceed its short-term liabilties (8B CHF).
BARN's long-term assets (13B CHF) exceed its long-term liabilties (10B CHF).
BARN's Revenue is forecast to grow at a rate of 10% per year over the next 3 years.
BARN has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
BARN has positive Net Income for the last twelve months.
BARN's Revenue has been growing by 11% per year for the last 3 years.
BARN's D/E (Debt to Equity) is very low and is equal to 0.79.
BARN's Altman Z-Score is very low and is equal to 1.78.
BARN has positive Net Debt. This means that the company has more debt (2B CHF) than cash and short-term investments (428m CHF).
BARN generates enough operating income (489m CHF) to cover interest payments on its debt (140m CHF).
Valuation Backtest
Barry Callebaut AG
Run backtest to discover the historical profit from buying and selling
BARN
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Barry Callebaut AG
| Current Assets | 10.4B |
| Cash & Short-Term Investments | 428m |
| Receivables | 2.2B |
| Other Current Assets | 7.8B |
| Non-Current Assets | 2.9B |
| PP&E | 1.8B |
| Intangibles | 902.2m |
| Other Non-Current Assets | 226m |
| Current Liabilities | 8.2B |
| Accounts Payable | 2B |
| Short-Term Debt | 247.8m |
| Other Current Liabilities | 5.9B |
| Non-Current Liabilities | 2.2B |
| Long-Term Debt | 2B |
| Other Non-Current Liabilities | 206.8m |
Earnings Waterfall
Barry Callebaut AG
|
Revenue
|
8.9B
CHF
|
|
Cost of Revenue
|
-7.6B
CHF
|
|
Gross Profit
|
1.3B
CHF
|
|
Operating Expenses
|
-858.4m
CHF
|
|
Operating Income
|
489m
CHF
|
|
Other Expenses
|
-202.2m
CHF
|
|
Net Income
|
286.8m
CHF
|
Free Cash Flow Analysis
Barry Callebaut AG
| CHF | |
| Free Cash Flow | CHF |
BARN Profitability Score
Profitability Due Diligence
Barry Callebaut AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Barry Callebaut AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
BARN Solvency Score
Solvency Due Diligence
Barry Callebaut AG's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Barry Callebaut AG's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BARN Price Targets Summary
Barry Callebaut AG
According to Wall Street analysts, the average 1-year price target for
BARN
is 1 743.01 CHF
with a low forecast of 1 363.5 CHF and a high forecast of 2 940 CHF.
Click here to dive deeper.
Price Appreciation
BARN Price
Barry Callebaut AG
| Average Annual Return | -0.19% |
| Standard Deviation of Annual Returns | 10.36% |
| Max Drawdown | -47% |
| Market Capitalization | 7.7B CHF |
| Shares Outstanding | 5 487 746 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Barry Callebaut AG
Country
Industry
Market Cap
Dividend Yield
Description
Barry Callebaut AG engages in the manufacture and trade of cocoa, chocolate, and confectionery products. The company is headquartered in Zurich, Zuerich and currently employs 13,289 full-time employees. The firm produces cocoa, chocolate and confectionery products for the food industry, from industrial food manufacturers to artisanal and professional users of chocolate, such as chocolatiers, pastry chefs, bakers, hotels, restaurants or caterer. Its manufacturing process involves all stages of the cocoa and chocolate value chain from the sourcing of raw materials to the delivery of the finished products. The Company’s global activities are divided into four geographic-based segments: Global Cocoa, Europe, Americas, and Asia Pacific. The firm operates more than 50 chocolate and cocoa factories, and is present in over 30 countries. The firm operates Nyonkopa, a licensed buying company based in Ghana, as a subsidiary.
Contact
IPO
Employees
Officers
The intrinsic value of one
BARN
stock under the Base Case scenario is
1 940.98
CHF.
Compared to the current market price of 1 408 CHF,
Barry Callebaut AG
is
Undervalued by 27%.
You don't have any saved screeners yet
